Core Viewpoint - Western Forest Products Inc. has amended its $250 million syndicated credit facility to include a new US$30 million bilateral letter of credit facility with the Royal Bank of Canada, which is guaranteed by Export Development Corporation of Canada [1]. Company Overview - Western Forest Products Inc. is an integrated forest products company focused on building a margin-oriented log and lumber business to compete in global softwood markets [2]. - The company operates primarily on the coast of British Columbia and Washington State, supplying high-value specialty forest products to global markets [2]. - Western has a lumber capacity of 780 million board feet from six sawmills, along with four remanufacturing facilities and two glulam manufacturing facilities [2]. - Timber is sourced from long-term licenses, First Nations arrangements, and market purchases, supplemented by a wholesale program offering a comprehensive range of specialty products [2].

Rewards startup Fetch increased the size of its credit facility with Morgan Stanley’s private credit arm by roughly 30% to $110 million as it prepares to launch a new platform and push deeper into AI https://t.co/XUdFoxJM6Y ...

Group 1 - Suominen Corporation has entered into a EUR 50 million term loan and a EUR 50 million revolving credit facility agreement with a maturity of three years and a one-year extension option [1][2] - The new credit facility replaces the existing EUR 100 million syndicated revolving credit facility [2] - The lenders for the new facility are Danske Bank A/S and Nordea Bank Abp, and it includes leverage ratio and gearing as financial covenants [1] Group 2 - Suominen manufactures nonwovens for wipes and other applications, aiming to be a leader in nonwovens innovation and sustainability [3] - The company's net sales in 2024 were EUR 462.3 million, and it employs over 700 professionals in Europe and the Americas [3] - Suominen's shares are listed on Nasdaq Helsinki [3]

Core Viewpoint - Wesdome Gold Mines Ltd. has successfully amended and restated its credit agreement, increasing and extending its secured revolving credit facility to a total of up to US$300 million, maturing on June 19, 2028, which is a significant enhancement from the previous facility [1][2]. Group 1: Credit Facility Details - The new credit facility includes aggregate commitments of US$250 million, with an additional accordion of US$50 million, representing approximately a twofold increase from the current facility [2]. - Advances under the credit facility will incur interest at the Secured Overnight Financing Rate (SOFR) plus a margin of 2.25% to 3.25% per annum, depending on the company's leverage ratio [3]. - The credit facility can be utilized for general corporate purposes, including acquisitions, distributions, investments, and ongoing mine development [3]. Group 2: Management Commentary - The President and CEO of Wesdome expressed gratitude to the lenders for their support, highlighting that the increased credit facility and improved terms reflect the quality of the company's assets and progress made [3]. Group 3: Financial Advisors and Arrangers - National Bank Financial Inc. acted as the sole lead arranger and bookrunner, while Bank of Montreal served as the syndication agent [4]. - The syndicate of lenders includes National Bank of Canada, Bank of Montreal, Fédération des Caisses Desjardins du Québec, and Canadian Imperial Bank of Commerce [4]. - GenCap Mining Advisory provided credit advisory services to Wesdome regarding the financing [4]. Group 4: Company Overview - Wesdome Gold Mines is a Canadian-focused gold producer with two high-grade underground assets located in Northern Ontario and Val-d'Or, Québec [6]. - The company's primary objective is to leverage its operating platform and exploration pipeline to build a growing, value-driven gold production business [6].

Core Points - Reeflex Solutions Inc. has entered into a credit agreement with the Royal Bank of Canada to support its growth and operational flexibility [1][3] - The credit facilities include a $1 million revolving demand facility and a $500,000 revolving term facility [2] - The financing is seen as a vote of confidence in the company's business model and management team [3] Credit Facilities Details - The revolving demand facility bears interest at the Royal Bank Prime Rate + 1.25% [2] - The revolving term facility consists of variable and fixed rate term loans with terms up to 72 months [2] - Specific repayment terms will be agreed upon at the time of drawdown [2] Security and Obligations - The credit agreement is secured by a General Security Agreement and a personal guarantee from an officer and director of the company [3] - It includes standard financial reporting obligations and customary fees such as an annual renewal fee, arrangement fee, and monthly management fee [4] Company Overview - Reeflex is a public company providing advanced engineering and manufacturing solutions across various industry sectors [5] - Through its subsidiary, Coil Solutions Inc., the company offers coil tubing injectors and downhole tools for the oil and gas sector [5] - The manufacturing division, Ranglar Manufacturing, specializes in custom-designed mobile equipment for a wide range of industrial applications [5]

Core Viewpoint - West Red Lake Gold Mines Ltd. has drawn the final tranche of US$12.5 million from a US$35 million credit facility with Nebari Natural Resources Credit Fund II LP to support the restart of the Madsen Mine and other corporate expenses [1][3]. Credit Facility Details - The credit facility was established on December 31, 2024, with the first drawdown of US$15 million and a second tranche of US$7.5 million [2]. - The repayment structure includes 50% of the principal being repaid via fixed straight-line amortization starting 15 months after the first tranche drawdown, with the remaining 50% due at maturity on June 30, 2028 [4][6]. - Interest on the loan will be based on a floating rate, which includes the three-month term SOFR plus 8.0% per annum, with a minimum interest rate of 4.0% [5]. Use of Proceeds - The proceeds from the final tranche will be allocated to complete capital costs for restarting the Madsen Mine and cover other corporate, exploration, and working capital expenses [3]. Warrants Issued - In connection with the final tranche, the company issued 4,158,875 non-transferable common share purchase warrants at an exercise price of CAD$0.85, expiring on June 30, 2028 [7]. - The warrants represent 20% of the loan amount drawn in the final tranche, subject to a statutory hold period of four months and one day [8]. Company Overview - West Red Lake Gold Mines Ltd. is focused on advancing its flagship Madsen Gold Mine and holds a significant land package in the Red Lake district of Ontario, known for its high-grade gold deposits [10].

Core Viewpoint - Altimmune, Inc. has secured a credit facility of up to $100 million from Hercules Capital to support the development of its novel peptide-based therapeutic, pemvidutide, aimed at treating liver and cardiometabolic diseases [1][2]. Financial Strength and Flexibility - The credit facility enhances Altimmune's balance sheet, which had $150 million in cash and cash equivalents as of March 31, 2025 [2]. - The initial tranche of $15 million will be drawn at closing, with additional funds available upon meeting specific clinical and financial milestones [3]. Development Plans for Pemvidutide - Pemvidutide is currently in a Phase 2b trial for metabolic dysfunction-associated steatohepatitis (MASH), with top-line data expected in Q2 2025 [2]. - Phase 2 trials for pemvidutide in Alcohol Use Disorder (AUD) and Alcohol Liver Disease (ALD) are anticipated to start in the second and third quarters of 2025, respectively [2]. Partnership and Future Outlook - The partnership with Hercules Capital is expected to extend Altimmune's cash runway under flexible terms, allowing for continued development of pemvidutide [3]. - Hercules Capital expresses enthusiasm in supporting Altimmune through its clinical development journey, particularly with the upcoming data release from the IMPACT trial [3]. Company Overview - Altimmune is a late clinical-stage biopharmaceutical company focused on developing peptide-based therapeutics for liver and cardiometabolic diseases, with pemvidutide as its lead program [4].